OTCMKTS:TMED Trimedyne Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Trimedyne, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.25 -0.01 (-0.23 %) (As of 03/20/2020) Add Compare Share Today's Range$4.25Now: $4.25▼$4.2550-Day Range$4.25MA: $4.25▼$4.2552-Week Range$3.48Now: $4.25▼$7.00Volume100 shsAverage Volume570 shsMarket Capitalization$522,750.00P/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Trimedyne. Previous Next 2.0 Community Rank Outperform VotesTrimedyne has received 66 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTrimedyne has received 96 “underperform” votes. (Add your “underperform” vote.)Community SentimentTrimedyne has received 59.26% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Trimedyne and other stocks. Vote “Outperform” if you believe TMED will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TMED will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTrimedyne does not currently pay a dividend.Dividend GrowthTrimedyne does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Trimedyne insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 11.10% of the stock of Trimedyne is held by insiders. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.40 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorComputer and Technology Current SymbolOTCMKTS:TMED Previous Symbol CUSIPN/A CIK357001 Webwww.trimedyne.com Phone949-951-3800Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5.57 million Price / Sales0.09 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares123,000Market Cap$522,750.00 Next Earnings Date10/6/2020 (Estimated) OptionableNot Optionable $4.25 -0.01 (-0.23 %) (As of 03/20/2020) 30 days | 90 days | 365 days | Advanced Chart Receive TMED News and Ratings via Email Sign-up to receive the latest news and ratings for TMED and its competitors with MarketBeat's FREE daily newsletter. Trimedyne (OTCMKTS:TMED) Frequently Asked Questions How has Trimedyne's stock been impacted by Coronavirus (COVID-19)? Trimedyne's stock was trading at $4.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TMED stock has decreased by 1.2% and is now trading at $4.25. View which stocks have been most impacted by COVID-19. When is Trimedyne's next earnings date? Trimedyne is scheduled to release its next quarterly earnings announcement on Tuesday, October 6th 2020. View our earnings forecast for Trimedyne. How were Trimedyne's earnings last quarter? Trimedyne, Inc. (OTCMKTS:TMED) released its quarterly earnings results on Tuesday, February, 20th. The technology company reported $0.70 EPS for the quarter. The technology company earned $1.53 million during the quarter. View Trimedyne's earnings history. Who are some of Trimedyne's key competitors? Some companies that are related to Trimedyne include 21st North (ULGX), Aksys (AKSY), Escalon Medical (ESMC), Heart Tronics (HRTT), IMRIS (IMRSQ), Ivivi Technologies (IVVI) and SpectraScience (SCIE). View all competitors. What other stocks do shareholders of Trimedyne own? Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include AFLAC (AFL), Diana Shipping (DSX), Cohen & Steers Clsd-End Optuny Fnd (FOF), Incyte (INCY), National Fuel Gas (NFG), PDC Energy (PDCE), Rank Group (RNK), Safehold (SAFE), Snap (SNAP) and Aramark (ARMK). Who are Trimedyne's key executives? Trimedyne's management team includes the following people: Mr. Glenn D. Yeik, Interim Chairman, CEO & Pres (Age 51)Mr. Brian T. Kenney, VP of Global Sales & Marketing (Age 62) What is Trimedyne's stock symbol? Trimedyne trades on the OTCMKTS under the ticker symbol "TMED." How do I buy shares of Trimedyne? Shares of TMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Trimedyne's stock price today? One share of TMED stock can currently be purchased for approximately $4.25. How big of a company is Trimedyne? Trimedyne has a market capitalization of $522,750.00 and generates $5.57 million in revenue each year. What is Trimedyne's official website? The official website for Trimedyne is www.trimedyne.com. How can I contact Trimedyne? Trimedyne's mailing address is 5 HOLLAND BLDG #223, IRVINE CA, 92618. The technology company can be reached via phone at 949-951-3800. This page was last updated on 9/30/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
